Stay updated on ABP798 vs Rituximab in NHL: Clinical Trial
Sign up to get notified when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.

Latest updates to the ABP798 vs Rituximab in NHL: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.4.2 was added, replacing v3.4.1, indicating a minor update. This does not modify study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoChange DetectedThe IPD Sharing section now lists Revision: v3.4.1, replacing v3.4.0, indicating a document version update.SummaryDifference0.0%

- Check32 days agoChange DetectedShow glossary option added; Last Update Submitted that Met QC Criteria label appears with capitalization changes and a new Revision: v3.4.0 notice. These are administrative updates and do not affect study content, eligibility, or locations; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision history updated to show Revision: v3.3.4 and removed Revision: v3.3.3. This update does not affect the study content, eligibility criteria, or results.SummaryDifference0.0%

- Check67 days agoChange DetectedThe Locations section now includes added sites across multiple countries and regions and removes several existing sites. This updates the official list of participating study sites for the trial.SummaryDifference3%

- Check89 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed, indicating a minor site version update with no changes to the study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ABP798 vs Rituximab in NHL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.